Strs Ohio Purchases New Position in Privia Health Group, Inc. $PRVA

Key Points

• Strs Ohio has invested $849,000 in Privia Health Group, purchasing 37,800 shares of the stock, indicating growing interest from institutional investors.
• Analysts have differing opinions on the stock, with a consensus rating of "Moderate Buy" and an average target price of $28.58 following recent upgrades and downgrades.
• Privia Health Group reported a revenue of $521.15 million for the last quarter, exceeding expectations, though earnings per share missed consensus estimates by $0.03.

Strs Ohio acquired a new stake in Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 37,800 shares of the company's stock, valued at approximately $849,000.

Other hedge funds have also bought and sold shares of the company. ProShare Advisors LLC raised its holdings in Privia Health Group by 44.5% in the 4th quarter. ProShare Advisors LLC now owns 30,770 shares of the company's stock valued at $602,000 after acquiring an additional 9,475 shares during the period. Two Sigma Investments LP increased its position in Privia Health Group by 153.9% during the 4th quarter. Two Sigma Investments LP now owns 219,839 shares of the company's stock worth $4,298,000 after purchasing an additional 133,239 shares in the last quarter. Two Sigma Advisers LP acquired a new position in Privia Health Group during the 4th quarter worth approximately $940,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC increased its position in Privia Health Group by 13.9% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 939,170 shares of the company's stock worth $18,361,000 after purchasing an additional 114,647 shares in the last quarter. Finally, Neo Ivy Capital Management increased its position in Privia Health Group by 81.5% during the 4th quarter. Neo Ivy Capital Management now owns 6,540 shares of the company's stock worth $127,000 after purchasing an additional 2,936 shares in the last quarter. 94.48% of the stock is currently owned by institutional investors and hedge funds.

Privia Health Group Trading Up 1.2%

Shares of PRVA traded up $0.28 during midday trading on Tuesday, reaching $23.18. The stock had a trading volume of 37,446 shares, compared to its average volume of 838,386. The company's 50-day moving average is $21.28 and its 200 day moving average is $22.39. Privia Health Group, Inc. has a 12-month low of $16.47 and a 12-month high of $26.09. The company has a market capitalization of $2.84 billion, a price-to-earnings ratio of 210.75, a price-to-earnings-growth ratio of 3.24 and a beta of 0.82.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last posted its quarterly earnings data on Thursday, August 7th. The company reported $0.02 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). Privia Health Group had a return on equity of 2.13% and a net margin of 0.78%.The firm had revenue of $521.15 million during the quarter, compared to analysts' expectations of $466.97 million. During the same quarter in the previous year, the company posted $0.19 earnings per share. Privia Health Group's revenue for the quarter was up 23.4% compared to the same quarter last year. Privia Health Group has set its FY 2025 guidance at EPS. Research analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research firms recently issued reports on PRVA. Stephens reiterated an "overweight" rating and set a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, September 4th. Evercore ISI reduced their target price on shares of Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. Zacks Research raised shares of Privia Health Group from a "strong sell" rating to a "hold" rating in a report on Tuesday, August 19th. Piper Sandler reduced their target price on shares of Privia Health Group from $36.00 to $35.00 and set an "overweight" rating on the stock in a report on Monday, August 11th. Finally, JMP Securities boosted their target price on shares of Privia Health Group from $29.00 to $30.00 and gave the stock a "market outperform" rating in a report on Friday, August 29th. One investment analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and two have given a Hold rating to the company's stock. According to data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $28.58.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.